Get 20% lifetime commission for referring investors to digrin.com
here.
Prelude Therapeutics Incorporated ( PRLD) - Key Metrics
PRLD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.06 | -$0.14 | -$0.16 | -$0.16 |
| 2026Q1 | $0.06 | -$0.13 | -$0.26 | -$0.26 |
| 2025Q4 | $0.09 | -$0.26 | $0.37 | $0.37 |
| 2025Q3 | $0.09 | -$0.26 | -$0.25 | -$0.25 |
| 2025Q2 | $0 | -$0.41 | -$0.34 | -$0.34 |
PRLD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.52 |
| 2026Q1 | 0% | -6.58 |
| 2025Q4 | 0% | -2.79 |
| 2025Q3 | 0% | -1.38 |
| 2025Q2 | 0% | -0.49 |
PRLD
Price: $5.63
52 week price:
Earnings Per Share: -0.73 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 65500
Market Capitalization: 442.9 million